A Dark Vector Cognition product

Item 16. Form 10-K Summary

3K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary

Not applicable.

​

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

​​​
AXON ENTERPRISE, INC.​​
​​​
Date: February 27, 2024​​
​By:/s/ PATRICK W. SMITH
​​Chief Executive Officer, Director
​​(Principal Executive Officer)
​​​
Date: February 27, 2024By:/s/ BRITTANY BAGLEY
​​Chief Operating Officer and Chief Financial Officer
​​(Principal Financial and Accounting Officer)

​

​

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Patrick W. Smith his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her in any and all capacities, to sign any amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his substitute or substitutes, may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SignatureTitleDate
​​​​​
​​Chief Executive Officer, Director​​
/s/ PATRICK W. SMITH​(Principal Executive Officer)​February 27, 2024
Patrick W. Smith​​​​
​​​​​
​​Chief Operating Officer and Chief Financial Officer​​
/s/ BRITTANY BAGLEY​(Principal Financial and Accounting Officer)​February 27, 2024
Brittany Bagley​​​​
​​​​​
/s/ ERIKA AYERS BADAN​Director​February 27, 2024
Erika Ayers Badan​​​​
​​​​​
/s/ ADRIANE M. BROWN​Director​February 27, 2024
Adriane M. Brown​​​​
​​​​​
/s/ JULIE A. CULLIVAN​Director​February 27, 2024
Julie A. Cullivan​​​​
​​​​​
/s/ MICHAEL GARNREITER​Director​February 27, 2024
Michael Garnreiter​​​​
​​​​​
/s/ CAITLIN E. KALINOWSKI​Director​February 27, 2024
Caitlin E. Kalinowski​​​​
​​​​​
/s/ MARK W. KROLL​Director​February 27, 2024
Mark W. Kroll​​​​
​​​​​
/s/ MATTHEW R. MCBRADY​Director​February 27, 2024
Matthew R. McBrady​​​​
​​​​​
/s/ HADI PARTOVI​Director​February 27, 2024
Hadi Partovi​​​​
​​​​​
/s/ GRAHAM SMITH​Director​February 27, 2024
Graham Smith​​​​
​​​​​
/s/ JERI WILLIAMS​Director​February 27, 2024
Jeri Williams​​​​

​

​

Previous: Item 15. Exhibits, Financial Statement Schedules